Atrioventricular Nodal Reentrant Tachycardia

Published on 02/03/2015 by admin

Filed under Cardiovascular

Last modified 02/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 3 (1 votes)

This article have been viewed 4756 times

Chapter 17 Atrioventricular Nodal Reentrant Tachycardia

Pathophysiology

Anatomy and Physiology of the Atrioventricular Node

The atrioventricular (AV) junction is a complex structure, located within an area called the triangle of Koch (Fig. 17-1).1 The triangle of Koch is bounded by the coronary sinus ostium (CS os) posteriorly, the tricuspid annulus (the attachment of the septal leaflet of the tricuspid valve) inferiorly, and the tendon of Todaro anteriorly and superiorly. The triangle of Koch is septal in location and constitutes the right atrial (RA) endocardial surface of the muscular AV septum. The compact AV node (AVN) lies just beneath the RA endocardium, at the apex of the triangle of Koch, anterior to the CS os, and directly above the insertion of the septal leaflet of the tricuspid valve, where the tendon of Todaro merges with the central fibrous body. Slightly more anteriorly and superiorly is where the His bundle (HB) lies. The mean distances from the HB electrogram recording site to the upper and lower lips of the CS os are 10 mm (range, 0 to 23 mm), and 20 to 25 mm (range, 9 to 46 mm), respectively. However, the contour of the Koch triangle may be small or even horizontal in some patients.24

Functionally, based on activation times during anterograde or retrograde propagation, or both, and on the action potential characteristics from microelectrode recordings in the rabbit AV junction, the cells of the AVN region are frequently described as AN (atrionodal), N (nodal), and NH (nodal-His). The transition from one cell area to the other is gradual, with intermediate cells exhibiting intermediate action potentials with great changes related to the autonomic tone.26

The AN region corresponds to the cells in the transitional zone, which are activated shortly after the atrial cells. The transitional cell zone represents the inferior, more open portion of the AVN into which atrial bands gradually merge (i.e., the approaches from the working atrial myocardium to the AVN). Transitional cells are histologically distinct from both the cells of the compact AVN and the working atrial myocytes. Transitional cells are not insulated from the surrounding myocardium but tend to be separated from one another by thin fibrous strands. The connections between atrial and transitional cells are so gradual that no clear anatomical demarcations can be detected.7 Transitional cells do not represent conducting tracts, but rather a bridge funneling of atrial depolarization into the compact AVN through discrete AVN inputs (approaches). In humans and animals, two such inputs are commonly recognized in the right septal region: the anterior (superior) approaches, which travel from the anterior limbus of the fossa ovalis and merge with the AVN closer to the apex of the triangle of Koch, and the posterior (inferior) approaches, located in the inferoseptal RA and which serve as a bridge with the atrial myocardium at the CS os. Although both inputs have traditionally been assumed to be RA structures, growing evidence supports the AV conduction apparatus as a transseptal structure that reaches both atria. A third, middle group of transitional cells has also been identified to account for the nodal connections with the septum and left atrium (LA).2,5,812

The N region corresponds to the compact AVN, the region where transitional cells merge with midnodal cells. The N cells represent the most typical of the nodal cells because they are characterized by a less negative resting membrane potential and low action potential amplitude (mediated by the L-type calcium [Ca+2] current), slow rates of depolarization and repolarization, few intercellular connections such as gap junctions, and reduced excitability compared with surrounding cells. The N cells in the compact AVN appear to be responsible for the major part of AV conduction delay. Sodium channel density is lower in the midnodal zone of the AVN than in the AN and NH cell zones, and the inward L-type Ca2+ current is the basis of the upstroke of the N cell action potential. Therefore, conduction is slower through the compact AVN than through the AN and NH cell zones.1,6 Fast pathway conduction through the AVN apparently bypasses many of the N cells by transitional cells, whereas slow pathway conduction traverses the entire compact AVN. Importantly, the recovery of excitability after conduction of an impulse is faster for the slow pathway than for the fast pathway for reasons that are unclear.5,6,13

The NH region corresponds to the lower nodal cells, typically distal to the site of Wenckebach block, connecting to the insulated penetrating portion of the HB. The action potentials of the NH cells are closer in appearance to the fast-rising and long action potentials of the HB.

When traced inferiorly, toward the base of the triangle of Koch, the compact AVN area separates into two extensions, usually with the artery supplying the AVN running between them. The prongs bifurcate toward the CS os and tricuspid annulus (right posterior extension) and toward the mitral annulus (left posterior extension). The right posterior nodal extension has been implicated as the anatomical substrate for the so-called slow pathway in the AVN reentrant tachycardia (AVNRT) circuit. The tachycardia circuit may seldom involve the left posterior nodal extension (see later). The fast pathway is less well defined from an anatomical and structural standpoint. The probable anatomical substrate of this pathway consists of the transitional cell layers located around the compact AVN at the interface between the compact node and transitional cells.3,4,12,14 The HB connects with the distal part of the compact AVN and passes through the fibrous core of the central fibrous body in a leftward direction (away from the RA endocardium and toward the ventricular septum). The HB then continues through the annulus fibrosis, where it is called the nonbranching portion as it penetrates the membranous septum, along the crest of the left side of the interventricular septum, for 1 to 2 cm and then divides into the right bundle branch (RB) and left bundle branch (LB). The HB is insulated from the atrial myocardium by the membranous septum and from the ventricular myocardium by connective tissue of the central fibrous body.1 Viewed from the left ventricle (LV), the HB is marked by the area of fibrous continuity between the aortic and mitral valves adjacent to the membranous septum. Viewed from the aorta, the HB passes beneath the part of the membranous septum that adjoins the interleaflet fibrous triangle between the right and noncoronary sinuses.12

Tachycardia Circuit

The concept of AVN reentry is related, but not identical, to the so-called dual pathway electrophysiology. It is well established that dual AVN physiology is the underlying substrate for AVNRT; however, it is important to recognize that dual AVN physiology characterizes the normal AVN electrophysiology, and the presence of dual (or multiple) AVN pathways is not necessarily indicative of the existence of functional reentry, although it is required to maintain the reentry circuit. Nevertheless, the presence of dual AVN physiology provides the natural substrate for the occurrence of AVN reentry. In the absence of an animal model, however, the exact pathophysiological substrate for AVNRT remains uncertain.4

The AVNRT circuit does not involve the ventricles, but whether the circuit is confined to the compact AVN (subatrial) or involves a component of perinodal atrial myocardium is controversial. There is good evidence that the distal junction of the slow and fast pathways is located in the AVN, with the existence of a region of AVN tissue extending between the distal junction of the two pathways and the HB (called the lower common pathway), at least in a subset of patients (Table 17-1). However, the nature of the proximal link between these pathways is unclear, and the existence of an upper common pathway is still a matter of controversy (Tables 17-2 and 17-3). Based on rare cases of dissociation of atrial activation from the tachycardia (e.g., persistence of AVNRT during different patterns of VA block) and on similarities between fast-slow AV conduction and longitudinal-transverse conduction in nonuniform anisotropy, early studies proposed that AVNRT results from reentry within the compact AVN because of functional longitudinal dissociation within the AVN into fast and slow pathways and suggested the presence of an upper common pathway, at least in a subset of patients.13,15

TABLE 17-1 Evidence against the Necessity of Ventricle in Reentrant Circuit*

VA Wenckebach CL during ventricular pacing longer than the tachycardia CL
HA interval during ventricular pacing at the tachycardia CL longer than that during AVNRT
AV block occurring without interruption of AVNRT
AES during AVNRT resulting in changes in the relative activation of HB and atrium (i.e., varying HA intervals)
VES during AVNRT prematurely depolarizing the HB without affecting the tachycardia

AES = atrial extrastimulation; AV = atrioventricular; AVNRT = atrioventricular nodal reentrant tachycardia; CL = cycle length; HA = His bundle–atrial; HB = His bundle; VA = ventriculoatrial; VES = ventricular extrastimulation.

* Supporting the presence of a lower common pathway.

From Josephson ME: Supraventricular tachycardias. In Josephson ME, editor: Clinical cardiac electrophysiology, ed 3, Philadelphia, 2002, Lippincott Williams & Wilkins, pp 168-271.

TABLE 17-2 Evidence for the Necessity of Atrium in Reentrant Circuit*

The finding that AES delivered to the inferior atrial septum close to the CS os during AVNRT just before the expected time of retrograde fast pathway conduction can activate the slow pathway and advance the SVT
The finding that cure of AVNRT can be produced by placing ablative lesions in the perinodal atrial myocardium, as much as 10 mm or more from the compact AVN
Differences in the site of earliest atrial activation between retrograde conduction over the fast and slow pathways
Microelectrode and extracellular recordings and optical mapping of AVN reentrant echo beats in animals

AES = atrial extrastimulation; AVN = atrioventricular node; AVNRT = atrioventricular nodal reentrant tachycardia; CS os = coronary sinus ostium; SVT = supraventricular tachycardia.

* That is, against the presence of an upper common pathway.

From Josephson ME: Supraventricular tachycardias. In Josephson ME, editor: Clinical cardiac electrophysiology, ed 3, Philadelphia, 2002, Lippincott Williams & Wilkins, pp 168-271.

TABLE 17-3 Evidence against the Necessity of Atrium in Reentrant Circuit*

Initiation of AVNRT in the absence of an atrial echo
AV Wenckebach CL during atrial pacing longer than the tachycardia CL
AH interval during atrial pacing at the tachycardia CL longer than that during AVNRT
Retrograde VA block occurring without interruption of AVNRT
AVNRT occurrence in the presence of AF
Depolarization of the atria surrounding the AVN without affecting the tachycardia
Resetting of the tachycardia by ventricular stimulation in the absence of atrial activation
Heterogeneous atrial activation during AVNRT that is incompatible with atrial participation
Changing VA relationship with minimal or no change in the tachycardia CL (suggesting that atrial activation is determined by the functional output to the atrium from the tachycardia and not causally related to it)

AF = atrial fibrillation; AH = atrial–His bundle; AV = atrioventricular; AVN = atrioventricular node; AVNRT = atrioventricular nodal reentrant tachycardia; CL = cycle length; VA = ventriculoatrial.

* Supporting the presence of an upper common pathway.

From Josephson ME: Supraventricular tachycardias. In Josephson ME, editor: Clinical cardiac electrophysiology, ed 3, Philadelphia, 2002, Lippincott Williams & Wilkins, pp 168-271.

Current evidence, derived from multielectrode recordings and optical mapping studies, supports the role of perinodal tissue and suggests that the fast and slow pathways involved in the reentrant circuit of AVNRT represent conduction over different atrionodal connections, thus making at least a small amount of atrial tissue a necessary part of the reentrant circuit (Video 19 image). As noted, the compact AVN is surrounded by transitional cells whose structure and function are intermediate between those of atrial and compact nodal cells. If one considers the compact AVN and the surrounding transitional cells as a functional AVN unit, which implies that the AVN tissue occupies the bulk of the triangle of Koch, then the AVN reentrant circuit may be considered as confined to the AVN. Therefore, much of the disagreement on the presence or absence of an upper common pathway and the role of the atrium in the genesis of the reentrant circuit may, in part, be related to the definition of the extent of the AVN.16

Nevertheless, the understanding of the AVN as having superior (anterior) and inferior (posterior) inputs that form the fast and slow pathways, respectively, is a simple conceptual framework that seems to enable the clinician to confront most cases. Reentry occurring along these pathways is the basic mechanism for the various subtypes of AVNRT. The proximal atrial insertions of the fast and slow pathways are anatomically distinct during retrograde conduction, and several important functional differences exist between the two pathways (Table 17-4).13,14

TABLE 17-4 Functional Differences between Fast and Slow Atrioventricular Node Pathways

The fast pathway forms the normal physiological conduction axis, and the AH interval during conduction over the fast pathway is usually no longer than 220 msec. Longer AH intervals can be caused by conduction over the slow pathway.
Anterograde ERP of the fast pathway is usually longer than that of the slow pathway. However, many exceptions exist.
Adrenergic stimulation tends to shorten the anterograde and retrograde ERP of the fast pathway to a greater extent than that of the slow pathway. Conversely, beta blockers tend to prolong ERP of the fast pathway more than that of the slow pathway.
The earliest atrial activation site during retrograde conduction over the fast pathway is in the anterior apex of the triangle of Koch at the same site recording the proximal His potential (although some studies showed the earliest site of atrial activation occurring in the anterior interatrial septum above the tendon of Todaro, outside the triangle of Koch), whereas that over the slow pathway is in the base of the triangle of Koch.

AH = atrial–His bundle; ERP = effective refractory period.

Multiple slow pathways (as demonstrated by multiple discontinuities in the AVN function curves; see later) are present in up to 14% of patients with AVNRT, although not all these pathways are involved in the initiation and maintenance of AVNRT. Whether these pathways represent discrete anatomically distinct circuits or are functionally present because of nonuniform anisotropy is unclear. Frequently, multiple slow pathways are in close proximity within the triangle of Koch, and elimination of multiple slow pathways with radiofrequency (RF) ablation at one site is observed in approximately 42% of cases. Slow pathways with longer conduction times have a more inferior location in the triangle of Koch when compared with locations producing a shorter atrial-HB (AH) interval.

Types of Atrioventricular Nodal Reentry

Slow-Fast (Typical, Common) Atrioventricular Nodal Reentrant Tachycardia

Typical AVNRT accounts for 90% of AVNRTs. The reentrant circuit uses the slow AVN pathway anterogradely and the fast pathway retrogradely. The earliest atrial activation during typical AVNRT is usually in the apex of the triangle of Koch; however, retrograde atrial activation over the fast pathway is heterogeneous and may be found at the CS os or on the left side of the septum in up to 9% of patients (Fig. 17-2).8,13,17,18

During typical AVNRT, atrial and ventricular activations occur almost simultaneously. The AH interval is relatively long (more than 200 milliseconds) and the HA interval is relatively short (less than 70 milliseconds), resulting in a short RP tachycardia.

The presence of a lower common pathway in typical AVNRT remains controversial. Although some studies suggested the existence of a lower common pathway in most patients with typical AVNRT, others demonstrated that most patients with AVNRT without evidence of a substantial lower common pathway had typical AVNRT (i.e., the lower turnaround is within the proximal HB), and the presence of a lower common pathway was strongly associated with the atypical variants of AVNRT. Nevertheless, it is recognized that the lower common pathway in typical AVNRT, if present, is very short (as assessed by the degree of HB prematurity required for a ventricular extrastimulus [VES] to reset the tachycardia, and by comparing the HB-atrial (HA) interval during AVNRT with that during ventricular pacing at the tachycardia cycle length [CL]).8

Left Variant of Atrioventricular Nodal Reentrant Tachycardia

It has been known for some time that the slow pathway may be composed of both rightward and leftward posterior nodal extensions. The rightward extensions travel anatomically in the triangle of Koch between the tricuspid annulus and the CS os. The leftward extensions travel within the myocardial coat of the proximal CS leftward (transseptally) toward the left inferoseptal region and mitral annulus. These leftward extensions can then connect with the rightward extensions in the triangle of Koch anterior to the CS os. The leftward inferior extension can provide an LA input to the AVN, as suggested by functional studies showing preferential access to the AVN from the left inferior septum. Clinically, the leftward inferior nodal extension can behave as the slow pathway and lead to AVNRT. In the typical (slow-fast) form of AVNRT, this would render ablation in the usual inferoseptal RA ineffective and lead to the necessity of ablating inside the CS or on the posterior mitral annulus.8 In atypical forms of AVNRT, if the leftward inferior extension serves as the slow pathway conducting retrogradely, then the earliest atrial activation would be recorded in the LA, thus leading to eccentric CS activation.9

Eccentric retrograde atrial activation sequences that are suggestive of leftward atrionodal extensions of the slow AVN pathway have been described in AVNRT, but the exact incidence is unknown. Various reports have shown a higher incidence of the eccentric CS activation pattern among patients with atypical (14% to 80%) than those with typical (0% to 8%) forms of AVNRT.8,18,20,21 However, even in the presence of eccentric retrograde atrial activation during AVNRT, the significance of such leftward extensions to the AVNRT circuit has been debated. Whether the retrograde left-sided atrionodal connection constitutes the critical component of the reentrant circuit or is only an innocent bystander in atypical AVNRT with the eccentric CS activation pattern is controversial. It may be possible for both the leftward and rightward extensions, either together or separately, to participate in nodal reentry. Right-sided ablation is probably sufficient for most of these patients. However, in some patients, the slow pathway participating in the reentrant circuit cannot be ablated from the posteroseptal RA or the CS os, but it can be eliminated by ablation along the roof of the CS, as much as 5 to 6 cm from the CS os, or mitral annulus. In one report, direct left-sided ablation to the earliest retrograde activation site inside the CS (without ablation at the conventional site of the slow pathway) rendered the tachycardias noninducible in all 18 patients, a finding suggesting that the left-sided slow pathway constituted critical parts of the reentrant circuit.8,22

Clinical Considerations

Epidemiology

AVNRT is the most common form of paroxysmal supraventricular tachycardia (SVT). The absolute number of patients with AVNRT and its proportion of paroxysmal SVT increase with age. The reason may be related to the normal evolution of AVN physiology over the first two decades of life, as well as to age-related changes in atrial and nodal physiology observed in later decades.24 AVNRT is unusual in children less than 5 years of age, and it typically initially manifests in early life (e.g., in the teens). Conversely, atrioventricular reentrant tachycardia (AVRT) manifests earlier, with an average of more than 10 years separating the time of clinical presentation of AVRT and that of AVNRT. There is also a striking 2:1 predominance of AVNRT in women, in whom symptoms start at a significantly younger age.24,25 In fact, female sex and older age (i.e., teens versus newborns or young children) favor the diagnosis of AVNRT over AVRT.26 Gender differences in the anterograde and retrograde AVN electrophysiological (EP) properties have been observed and may contribute to the pathogenesis of AVNRT.25

Clinical Presentation

Patients with AVNRT typically present with the clinical syndrome of paroxysmal SVT. This is characterized as regular rapid tachycardia of abrupt onset and termination. Patients commonly describe palpitations and dizziness. Rapid ventricular rates can be associated with complaints of dyspnea, weakness, angina, or even frank syncope and can at times be disabling. Episodes can last from seconds to several hours. Patients often learn to use certain maneuvers such as carotid sinus massage or the Valsalva maneuver to terminate the arrhythmia, although many require pharmacological treatment. There is no significant association of AVNRT with other types of structural heart disease.

About half of patients with typical AVNRT report experiencing a pounding sensation in the neck during tachycardia, which is caused by simultaneous contraction of the atria and ventricles against closed mitral and tricuspid valves. The physical examination correlate of this phenomenon is continuous pulsing cannon A waves in the jugular venous waveform (described as the “frog” sign). This clinical feature has been reported to distinguish paroxysmal SVT resulting from AVNRT from that caused by orthodromic AVRT. Although atrial contraction during AVRT occurs against closed AV valves, the longer VA interval results in separate ventricular and then atrial contraction and a relatively lower RA and venous pressure; therefore, the presence of palpitations in the neck is experienced less commonly (about 17%) in patients with AVRT.26

Principles of Management

Acute Management

Because maintenance of AVNRT is dependent on AVN conduction, maneuvers or drugs that slow AVN conduction can be used to terminate the tachycardia. Initially, maneuvers that increase vagal tone (e.g., Valsalva maneuvers, gagging, carotid sinus massage) are used.27 When vagal maneuvers are unsuccessful, termination can be achieved with antiarrhythmic drugs whose primary effects increase refractoriness and/or decrease conduction (negative dromotropic effect) over the AVN. Adenosine is the drug of choice and is successful in almost 100% of cases.27 Verapamil, diltiazem, and beta blockers also can terminate AVNRT and prevent induction. Digoxin, which has a slower onset of action than the other AVN blockers, is not favored for the acute termination of AVNRT, except if there are relative contraindications to the other agents. Class IA and IC sodium channel blockers can also be used in treating an acute event of AVNRT, a strategy that is rarely used when other regimens have failed. If AVNRT cannot be terminated with intravenous drugs, electrical cardioversion can always be used. Energies in the range of 10 to 50 J are usually adequate.8

Chronic Management

Because AVNRT is generally a benign arrhythmia that does not influence survival, the primary indication for its treatment relates to its impact on a patient’s quality of life. Factors that contribute to the therapeutic decision include the frequency and duration of tachycardia, tolerance of symptoms, the effectiveness and tolerance of antiarrhythmic drugs, the need for lifelong drug therapy, and the presence of concomitant structural heart disease. Patients who develop a highly symptomatic episode of paroxysmal SVT, particularly if it requires an emergency room visit for termination, can elect to initiate therapy after a single episode. In contrast, a patient who presents with minimally symptomatic episodes of paroxysmal SVT that terminate spontaneously or in response to Valsalva maneuvers may elect to be followed clinically without specific therapy.8,27

Once it is decided to initiate treatment for AVNRT, the question arises whether to initiate pharmacological therapy or to use catheter ablation. Because of its high efficacy (greater than 95%) and low incidence of complications, catheter ablation has become the preferred therapy over long-term pharmacological therapy and can be offered as an initial therapeutic option. It is reasonable to discuss catheter ablation with all patients suspected of having AVNRT. However, patients considering RF ablation must be willing to accept the risk, albeit low, of AV block and pacemaker implantation. For patients in whom ablation is not desirable or available, long-term pharmacological therapy may be effective.27

Most pharmacological agents that depress AVN conduction (including beta blockers and calcium channel blockers) can reduce the frequency of recurrences of AVNRT. If those agents are ineffective, class IA, IC, or III antiarrhythmic agents may be considered. In general, drug efficacy is in the range of 30% to 50%.8

Outpatients can use a single dose of verapamil, propranolol, or flecainide to terminate an episode of AVNRT effectively. This so-called pill in the pocket approach (i.e., administration of a drug only during an episode of tachycardia for the purpose of termination of the arrhythmia when vagal maneuvers alone are not effective) is appropriate to consider for patients with infrequent episodes of AVNRT that are prolonged but well tolerated, and it obviates exposure of patients to long-term and unnecessary therapy between rare arrhythmic events. This approach necessitates the use of a drug that has a short onset of action (i.e., immediate-release preparations).27 Candidate patients should be free of significant LV dysfunction, sinus bradycardia, and preexcitation. Single-dose oral therapy with diltiazem (120 mg) plus propranolol (80 mg) has been shown to be superior to both placebo and flecainide in terminating AVNRT.8,27

Electrocardiographic Features

P-QRS Relationship

In typical (slow-fast) AVNRT, the RP interval is very short (–40 to 75 milliseconds). Variation of the P-QRS relationship with or without block can occur during AVNRT, especially in atypical or multiple-form tachycardias.8 This phenomenon usually occurs when the conduction system and the reentry circuit are unstable during initiation or termination of the tachycardia, likely secondary to decremental conduction in the lower common pathway. The ECG manifestation of P-QRS variations with or without AV block during tachycardia, especially at the initiation of tachycardias or in cases of nonsustained tachycardias, should not be misdiagnosed as atrial tachycardias (ATs); these variations may represent atypical or, rarely, typical forms of AVNRT. Moreover, the variations can be of such magnitude that long RP tachycardia can masquerade for brief periods of time as short RP tachycardia.

Usually, the A/V ratio during AVNRT is equal to 1; however, 2:1 AV block can be present because of block below the reentry circuit (usually below the HB and, infrequently, in the lower common pathway). In such cases, narrow, inverted P wave morphology in the inferior leads inscribed exactly between QRS complexes strongly suggests AVNRT (Fig. 17-4). The incidence of reproducible sustained 2:1 AV block during induced episodes of AVNRT is approximately 10%. Rarely, VA block can occur because of block in an upper common pathway.8

In atypical (fast-slow) AVNRT, the RP interval is longer than the PR interval. In slow-slow AVNRT, the RP interval is usually shorter than, and sometimes equal to, the PR interval. Occasionally, the P wave is inscribed in the middle of the cardiac cycle, thus mimicking atrial flutter or AT with 2:1 AV conduction (Fig. 17-5).19 Slow-slow AVNRT can be associated with RP intervals and P wave morphology similar to that during orthodromic AV reentrant tachycardia (AVRT) using a posteroseptal AV BT. However, although both SVTs have the earliest atrial activation in the posteroseptal region, conduction time from that site to the HB region is significantly longer in AVNRT than in orthodromic AVRT. The results are a significantly longer RP interval in lead V1 and a significantly larger difference in the RP interval between lead V1 and inferior leads during AVNRT. Therefore, ΔRP interval (V1 – III) of more than 20 milliseconds suggests slow-slow AVNRT (sensitivity, 71%; specificity, 87%).

Electrophysiological Testing

EP testing is used to study the inducibility and mechanism of the SVT and to guide catheter ablation. Typically, three quadripolar catheters are positioned in the high RA, the right ventricular (RV) apex, and the HB region, and a decapolar catheter is positioned in the CS (see Fig. 4-7).

Baseline Observations during Normal Sinus Rhythm

Atrial Extrastimulation and Atrial Pacing During Normal Sinus Rhythm

Atrial-His Interval Jump

In contrast to the normal pattern of AVN conduction, in which the AH interval gradually lengthens in response to progressively shorter AES coupling intervals, patients with dual AVN physiology usually demonstrate a sudden increase (jump) in the AH interval at a critical AES (A1-A2) coupling interval (Fig. 17-6). Conduction with a short PR or AH interval reflects fast pathway conduction, whereas conduction with a long PR or AH interval reflects slow pathway conduction. The AH interval jump signals block of anterograde conduction of the progressively premature AES over the fast pathway (once the AES coupling interval becomes shorter than the fast pathway ERP) and anterograde conduction over the slow pathway (which has an ERP shorter than the AES coupling interval), with a longer conduction time (i.e., longer A2-H2 interval). A jump in the A2-H2 (or H1-H2) interval of 50 milliseconds or more in response to a 10-millisecond shortening of either the A1-A2 interval (i.e., AES coupling interval) or the A1-A1 interval (i.e., pacing CL) is defined as a discontinuous AVN function curve and is considered evidence of dual anterograde AVN pathways (see Fig. 4-23).8

image

FIGURE 17-6 Dual atrioventricular node (AVN) physiology. H1-H2 intervals (left) and A2-H2 intervals (right) are at various A1-A2 intervals, with a discontinuous AVN curve. At a critical A1-A2 interval, the H1-H2 and A1-H2 intervals increase markedly. At the break in the curves, atrioventricular nodal reentrant tachycardia is initiated.

(From Olgin JE, Zipes DP: Specific arrhythmias: diagnosis and treatment. In Libby P, Bonow RO, Mann DL, Zipes DP, editors: Braunwald’s heart disease: a textbook of cardiovascular medicine, ed 7, Philadelphia, 2008, Saunders, p 880.)

1:2 Response

Rapid atrial pacing or AES can result in two ventricular complexes to a single paced atrial impulse. The first ventricular complex is caused by conduction of the atrial impulse over the fast AVN pathway, and the second complex is caused by conduction over the slow AVN pathway (Fig. 17-7). This response requires unidirectional retrograde block in the slow AVN pathway. Typically, in the presence of dual AVN pathways, conduction propagates simultaneously over both fast and slow AVN pathways. However, the wavefront conducting down the fast pathway reaches the distal junction of the two pathways before the impulse conducting down the slow pathway, and, subsequently, it conducts retrogradely up the slow pathway to collide with the impulse conducting anterogradely down that pathway. Thus, the anterograde impulse conducting down the slow pathway does not have the opportunity to reach the HB and ventricle. Rarely, the slow pathway conducts anterogradely only or has a very long retrograde ERP. In this setting, the wavefront traveling anterogradely down the fast pathway blocks (but does not conceal) in the slow pathway retrogradely and fails to retard the impulse traveling anterogradely down that pathway. Consequently, the wavefront traveling down the slow pathway can reach the HB and ventricle to produce a second His potential and QRS in response to a single atrial impulse. Because retrograde block in the slow pathway is a prerequisite to a 1:2 response, when such a phenomenon is present, it indicates that the slow pathway cannot support reentrant tachycardia using the slow pathway as the retrograde limb (i.e., atypical AVNRT cannot be operative). The 1:2 response should be differentiated from pseudo–simultaneous fast and slow pathway conduction, which is a much more common phenomenon during rapid atrial pacing. In the latter case, all paced atrial impulses block anterogradely in the fast pathway and conduct exclusively down the slow pathway with prolonged AH intervals (with PR intervals longer than atrial pacing CL), so that the last paced atrial impulse falls before the His potential caused by conduction of the preceding paced atrial impulse. Thus, the last paced atrial impulse is followed by two His potentials and two ventricular complexes. The last response may then be followed by induction of AVN echo beats or AVNRT, mimicking simultaneous fast and slow pathway conduction (Fig. 17-8).8,29

image

FIGURE 17-8 Induction of typical atrioventricular nodal reentrant tachycardia (AVNRT) with atrial pacing. A, Each of the atrial paced impulses (S1) conducts anterogradely over the slow AVN pathway. The last paced impulse, following anterograde conduction down the slow pathway, also conducts retrogradely up the fast AVN pathway to initiate typical AVNRT with right bundle branch block (RBBB). B, Each of the atrial paced impulses conducts anterogradely over the slow AVN pathway with a long PR interval (blue arrows); this is longer than the pacing cycle length (CL), resulting in crossing over, which can mimic a 1:2 AV response caused by anterograde conduction over both the fast and slow AVN pathways. Following anterograde conduction down the slow pathway, the last paced impulse also conducts retrogradely over the fast pathway, initiating typical AVNRT. Red arrows illustrate atrial activation sequence during atrial pacing versus AVNRT. C, Atrial pacing from the coronary sinus ostium (CS os) induces typical AVNRT. Each of the atrial paced impulses (S1) conducts over the fast AVN pathway except for the last paced impulse, which conducts over both the fast and slow AVN pathways (blue arrows), resulting in a 1:2 response (i.e., 2 ventricular responses); this is followed by induction of typical AVNRT with RBBB. The possibility of conduction of the paced atrial beats over the slow AVN pathway with a long atrial–His bundle (AH) interval (longer than the paced CL) is unlikely because the His potential preceding the first tachycardia complex (indicated by the green arrow) occurs later (i.e., at a longer AH interval) than what would be expected if that His potential was actually a result of conduction of the last atrial stimulus (as compared with the previous AH intervals). CSdist = distal coronary sinus; CSprox = proximal coronary sinus; HRA = high right atrium; RVA = right ventricular apex.

Different PR or AH Intervals During Normal Sinus Rhythm or At Identical Atrial Pacing Cycle Lengths

This phenomenon can occur when the fast pathway anterograde ERP is long relative to the sinus or paced CL (Fig. 17-9). Such a phenomenon also requires a long retrograde ERP of the fast pathway. Otherwise, AVN echo beats or AVNRT would result, because once the impulse blocks anterogradely in the fast pathway and is conducted down the slow pathway, it would subsequently conduct retrogradely up the fast pathway if the ERP of the fast pathway were shorter than the conduction time (i.e., shorter than the AH interval) over the slow pathway.8

Prevalence of Dual Atrioventricular Nodal Physiology

The presence of dual AVN pathways can usually be demonstrated by using a single AES or atrial pacing in 85% of patients with clinical AVNRT. In 95% of patients, the presence of dual AVN pathways can be shown by using multiple AESs, multiple-drive CLs (typically 600 and 400 milliseconds), and multiple pacing sites (typically high RA and CS). Failure to demonstrate dual AVN physiology in patients with AVNRT can be caused by similar fast and slow AVN pathway ERPs. Dissociation of refractoriness of the fast and slow AVN pathways may then be required. This can be achieved by any of the following: introduction of an AES at a shorter pacing drive CL; introduction of multiple AESs; burst atrial pacing; or administration of drugs such as beta blockers, verapamil, or digoxin. In general, if fast pathway conduction is suppressed in the baseline (as evidenced by a long AH interval at all atrial pacing rates or VA block during ventricular pacing), isoproterenol infusion (and occasionally atropine) usually facilitates fast pathway conduction. In contrast, if the baseline ERP of the fast pathway is very short, conduction over the slow pathway can be difficult to document. Increasing the degree of sedation or infusion of esmolol can prolong the fast pathway ERP and allow recognition of slow pathway conduction.

Another potential reason for the inability to demonstrate dual AVN physiology is block in the fast AVN pathway at the pacing drive CL (i.e., pacing drive CL is shorter than fast pathway ERP). Additionally, atrial FRP can limit the prematurity of the AES. Consequently, AVN activation cannot be adequately advanced to produce block in the fast pathway because a more premature AES would result in more intraatrial conduction delay and less premature stimulation of the AVN. This obstacle can be overcome by the introduction of an AES following a shorter pacing drive CL, introduction of multiple AESs, burst atrial pacing, or stimulation from multiple atrial sites. A typical programmed electrical stimulation protocol used for EP testing in patients with AVNRT is outlined in Table 17-5.28

TABLE 17-5 Programmed Stimulation Protocol for Electrophysiology Testing of Atrioventricular Nodal Reentrant Tachycardia

Atrial burst pacing from the RA and CS (down to AV Wenckebach CL)
Single and double AESs at multiple CLs (600-400 msec) from the high RA and CS (down to atrial ERP)
Ventricular burst pacing from the RV apex (down to VA Wenckebach CL)
Single and double VESs at multiple CLs (600-400 msec) from the RV apex (down to ventricular ERP)
Administration of isoproterenol infusion as needed to facilitate tachycardia induction (0.5-4 µg/min)

AES = atrial extrastimulus; AV = atrioventricular; CL = cycle length; CS = coronary sinus; ERP = effective refractory period; RA = right atrium; RV = right ventricle; VA = ventriculoatrial; VES = ventricular extrastimulus.

Ventricular Extrastimulation and Ventricular Pacing During Normal Sinus Rhythm

Retrograde Dual Atrioventricular Nodal Physiology

Demonstration of retrograde dual AVN pathway conduction curves requires a longer retrograde ERP of the fast pathway than slow pathway ERP and ventricular and His-Purkinje system (HPS) FRP, as well as a sufficient difference in conduction times between the two pathways. In a pattern analogous to that of anterograde dual AVN physiology, ventricular stimulation can result in discontinuous retrograde AVN function curves, manifesting as a jump in the H2-A2 (or A1-A2) interval of 50 milliseconds or more in response to a 10-millisecond decrement of the VES coupling interval (V1-V2) or ventricular pacing CL (V1-V1). This finding must be distinguished from sudden VA prolongation caused by VH interval (but not HA interval) prolongation related to retrograde functional block in the RB and transseptal activation of HB through the LB (see Fig. 4-27). A 1:2 response (i.e., two atrial responses to a single ventricular stimulus) can also be observed.28

Failure to demonstrate retrograde dual AVN physiology in patients with atypical AVNRT can be caused by similar fast and slow AVN pathway ERPs. Dissociation of refractoriness of the fast and slow AVN pathways may be required and usually can be achieved by any of the following: introduction of VESs at a shorter pacing drive CL; introduction of multiple VESs; burst ventricular pacing; or administration of drugs such as beta blockers, verapamil, or digoxin. In addition, retrograde block in the fast AVN pathway at the pacing drive CL (i.e., the pacing CL is shorter than the fast pathway ERP) and ventricular or HPS FRP interval limiting the prematurity of the VES can also account for such failure.28

Induction of Tachycardia

Initiation by Atrial Extrastimulation or Atrial Pacing

Buy Membership for Cardiovascular Category to continue reading. Learn more here